Glenmark Pharma shares upsurge 3%, subsidiary receives $700 million upfront payment from AbbVie
Glenmark Pharma shares rose 3% to an intraday high of ₹2,112.60 on Tuesday, September 9. The company announced that its wholly-owned subsidiary has received an upfront payment of $700 million…
